Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: ABVACC, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2021-05-17 to 2025-04-04
Current total value of award: $3467334.76
Description: TO DEVELOP A POTENT THERAPEUTIC MARBURGVIRUS MONOCLONAL ANTIBODY.